• Deep-Dive: ACTISAVE — Glenzocimab Fails to Beat Placebo on Top of tPA ± EVT

  August 10, 2026 · stroke deep-dive endovascular-thrombectomy thrombolysis intracerebral-hemorrhage clinical-trial

  ACTISAVE failed to confirm a beneficial effect of glenzocimab on mRS in patients with acute ischemic stroke treated by thrombolysis ± thrombectomy.

• Deep-Dive: Home-Based HIIT for Poststroke Fatigue — First RCT, Small N, Real Signal

  August 10, 2026 · stroke deep-dive rehabilitation clinical-trial poststroke-fatigue

  First RCT of home-based HIIT for poststroke fatigue: 8-week intervention cut S-FAS by 5.35 points and improved VO2peak by 4.48 mL/kg/min in 43 completers.

• Deep-Dive: LAMP Post-Hoc — Liraglutide Cuts Recurrent Stroke in Insulin-Resistant Patients

  August 10, 2026 · stroke deep-dive clinical-trial type-2-diabetes secondary-prevention

  LAMP post-hoc: liraglutide reduced recurrent stroke in insulin-resistant T2D stroke/TIA patients (HOMA-IR ≥ 2.5) but not in those with preserved insulin sensitivity.